Revance to Release First Quarter 2019 Financial Results on Wednesday, May 8, 2019
Conference Call Scheduled for
Individuals interested in listening to the conference call may do so by dialing (855) 453-3827 for domestic callers, or (484) 756-4301 for international callers and reference conference ID: 5753548; or from the webcast link in the investor relations section of the company’s website at: www.revance.com.
A replay of the call will be available beginning
"Revance Therapeutics" and the Revance logo are registered trademarks of
Nadine Tosk, 504-453-8344